Tweet
Translation Google
Equateur : 45,000 people targeted by the preventive campaign against the Ebola virus
Posted on Tue, 28/03/2023 - 07:05 | Modified on Tue, 28/03/2023 - 07:05
The preventive vaccination campaign against the Ebola virus disease was launched on Monday, March 27 in Mbandaka in the province of Equateur, by the vice-governor of the province, Taylor Nkeka.
The current vaccination campaign targets forty-five thousand people aged twelve and over. It is planned for six months, in the seven sites selected for vaccination across the three health zones of the city of Mbandaka:
Bolenge
Mbandaka
Wangata.
The head of Equateur provincial health division, Bienvenu Ikomo, was among the first to be vaccinated. He gave this testimony when he left:
“I received the vaccine 45 minutes ago. There is no effect. I still felt pain like any sting in the human body. But, in any case, there is no other effect after taking this vaccine”.
According to the coordinator of INRB field activities in Equateur, Zéphirin Mossoko, the DRC has experienced an epidemic of the Ebola virus disease ten times since the first appearance in 1976. Nearly half have raged in the greater Equateur area and three in the new province of Equateur, with several deaths.
This explains, he said, the need to prevent the disease:
“Professor Muyembe with the Johnson-Johnson Firm, we have decided that we should not wait for epidemics to start acting, when there are deaths. We must prevent with a prophylactic vaccine, which has been well studied and which has given very good results, here in the DRC and elsewhere”.
But, there are conditions to be vaccinated, said Doctor Zéphirin Mossoko:
“We have to be in good health. And even if you have a chronic disease, be it diabetes, hypertension, there is an eligible doctor who must consult you, take blood pressure and vital signs to see if you are in good health. So if you have a disease, which is not balanced, you will be asked to come back a few days after having balanced the disease”.
The Jonson-Jonson vaccine is given in two doses, 56 days apart.
Vaccination activities will be carried out by vaccinators from the National Institute for Biomedical Research (INRB) with support from the Management Unit of the Health Sector Development Program (UG-PDSS), with funding from the World Bank.
Equateur : 45,000 people targeted by the preventive campaign against the Ebola virus
Posted on Tue, 28/03/2023 - 07:05 | Modified on Tue, 28/03/2023 - 07:05
The preventive vaccination campaign against the Ebola virus disease was launched on Monday, March 27 in Mbandaka in the province of Equateur, by the vice-governor of the province, Taylor Nkeka.
The current vaccination campaign targets forty-five thousand people aged twelve and over. It is planned for six months, in the seven sites selected for vaccination across the three health zones of the city of Mbandaka:
Bolenge
Mbandaka
Wangata.
The head of Equateur provincial health division, Bienvenu Ikomo, was among the first to be vaccinated. He gave this testimony when he left:
“I received the vaccine 45 minutes ago. There is no effect. I still felt pain like any sting in the human body. But, in any case, there is no other effect after taking this vaccine”.
According to the coordinator of INRB field activities in Equateur, Zéphirin Mossoko, the DRC has experienced an epidemic of the Ebola virus disease ten times since the first appearance in 1976. Nearly half have raged in the greater Equateur area and three in the new province of Equateur, with several deaths.
This explains, he said, the need to prevent the disease:
“Professor Muyembe with the Johnson-Johnson Firm, we have decided that we should not wait for epidemics to start acting, when there are deaths. We must prevent with a prophylactic vaccine, which has been well studied and which has given very good results, here in the DRC and elsewhere”.
But, there are conditions to be vaccinated, said Doctor Zéphirin Mossoko:
“We have to be in good health. And even if you have a chronic disease, be it diabetes, hypertension, there is an eligible doctor who must consult you, take blood pressure and vital signs to see if you are in good health. So if you have a disease, which is not balanced, you will be asked to come back a few days after having balanced the disease”.
The Jonson-Jonson vaccine is given in two doses, 56 days apart.
Vaccination activities will be carried out by vaccinators from the National Institute for Biomedical Research (INRB) with support from the Management Unit of the Health Sector Development Program (UG-PDSS), with funding from the World Bank.
